Protocols for Hematopoietic Stem Cell Expansion from Umbilical Cord Blood
- 1 October 2009
- journal article
- review article
- Published by SAGE Publications in Cell Transplantation
- Vol. 18 (10-11), 1059-1068
- https://doi.org/10.3727/096368909x471288
Abstract
The reconstitution of adult stem cells may be a promising source for the regeneration of damaged tissues and for the reconstitution of organ dysfunction. However, there are two major limitations to the use of such cells: they are rare, and only a few types exist that can easily be isolated without harming the patient. The best studied and most widely used stem cells are of the hematopoietic lineage. Pioneering work on hematopoietic stem cell (HSC) transplantation was done in the early 1970s by ED. Thomas and colleagues. Since then HSCs have been used in allogenic and autologous transplantation settings to reconstitute blood formation after high-dose chemotherapy for various blood disorders. The cells can be easily harvested from donors, but the cell number is limited, especially when the HSCs originate from umbilical cord blood (UCB). It would be desirable to set up an ex vivo strategy to expand HSCs in order to overcome the cell dose limit, whereby the expansion would favor cell proliferation over cell differentiation. This review provides an overview of the various existing HSC expansion strategies—focusing particularly on stem cells derived from UCB—of the parameters that might affect the outcome, and of the difficulties that may occur when trying to expand such cells.Keywords
This publication has 71 references indexed in Scilit:
- Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantationBlood, 2008
- Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapiesMechanisms of Ageing and Development, 2008
- Biology of umbilical cord blood progenitors in bone marrow nichesBlood, 2007
- Maternal plasma or human serum albumin in wash buffer enhances enrichment and ex vivo expansion of human umbilical cord blood CD34+cellsBritish Journal of Haematology, 2007
- Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?Bone Marrow Transplantation, 2006
- Evaluation of ex vivo expansion and engraftment in NOD-SCID mice of umbilical cord blood CD34+ cells using the DIDECO ‘Pluricell System’Bone Marrow Transplantation, 2005
- The comparison of different protocols for expansion of umbilical-cord blood hematopoietic stem cellsJournal of Cellular and Molecular Medicine, 2004
- Retinoic acid‐mediated induction of neurons and glial cells from human umbilical cord‐derived hematopoietic stem cellsJournal of Neuroscience Research, 2003
- Evaluation of optimal survival of primitive progenitor cells (LTC-IC) from PBPC apheresis products after overnight storageBone Marrow Transplantation, 2000
- Congenital Cytomegalovirus InfectionNew England Journal of Medicine, 1982